PE Ratio
N/A
Thu, 28 Nov 2024 00:58:19 GMT
Summary:
Bristol-Myers Squibb price to earnings ratio is not available.BMY PE Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMY PE Ratio Performance
PeriodPeriod | PE ratioPE ratio | PricePrice | TTM EPSTTM EPS | TTM revenueTTM revenue |
---|---|---|---|---|
todaytoday | - | +1.3% | -10.1% | +2.0% |
1 m1 month | - | +14.4% | - | - |
3 m3 months | - | +23.4% | - | - |
6 m6 months | - | +43.6% | - | - |
ytdytd | - | +15.5% | - | - |
1 y1 year | - | +20.6% | -191.1% | +5.6% |
5 y5 years | - | +2.9% | -203.5% | +96.2% |
BMY PE Ratio High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1 month | ||||
3 m | 3 months | ||||
6 m | 6 months | ||||
1 y | 1 year | 14.10 | 12.39 | ||
3 y | 3 years | 28.36 | 12.32 | ||
5 y | 5 years | 79.12 | 12.32 | ||
alltime | all time | 259.38 | 4.13 |
Bristol-Myers Squibb PE Ratio History
Date | Value |
---|---|
2023 | 13.29(-45.5%) |
2022 | 24.39(+22.1%) |
2021 | 19.98(-31.8%) |
2019 | 29.31(+70.8%) |
2018 | 17.16(-83.2%) |
2017 | 102.13(+363.2%) |
2016 | 22.05(-68.9%) |
2015 | 70.92(+44.2%) |
2014 | 49.19(+43.5%) |
2013 | 34.29(+21.0%) |
2012 | 28.34(+72.9%) |
2011 | 16.39(+10.8%) |
2010 | 14.79(+212.0%) |
2009 | 4.74(-46.8%) |
2008 | 8.91(-63.4%) |
2007 | 24.33(-26.0%) |
Date | Value |
---|---|
2006 | 32.90(+116.2%) |
2005 | 15.22(-28.1%) |
2004 | 21.17(+17.7%) |
2003 | 17.99(-17.6%) |
2002 | 21.84(-55.9%) |
2001 | 49.51(+29.4%) |
2000 | 38.25(+13.3%) |
1999 | 33.75(-29.5%) |
1998 | 47.88(+68.0%) |
1997 | 28.50(+53.8%) |
1996 | 18.53(-19.3%) |
1995 | 22.96(+52.6%) |
1994 | 15.05(+4.2%) |
1993 | 14.44(-12.8%) |
1992 | 16.56(-21.9%) |
1991 | 21.21(+13.1%) |
1990 | 18.76 |
FAQ
- What is the all time high PE ratio for Bristol-Myers Squibb?
What is the all time high PE ratio for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high price to earnings ratio is 259.38